1. Home
  2. AMOD vs TRIB Comparison

AMOD vs TRIB Comparison

Compare AMOD & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMOD
  • TRIB
  • Stock Information
  • Founded
  • AMOD 2014
  • TRIB 1992
  • Country
  • AMOD United States
  • TRIB Ireland
  • Employees
  • AMOD N/A
  • TRIB N/A
  • Industry
  • AMOD
  • TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • AMOD
  • TRIB Health Care
  • Exchange
  • AMOD NYSE
  • TRIB Nasdaq
  • Market Cap
  • AMOD 26.1M
  • TRIB 25.5M
  • IPO Year
  • AMOD N/A
  • TRIB N/A
  • Fundamental
  • Price
  • AMOD $2.09
  • TRIB $0.77
  • Analyst Decision
  • AMOD
  • TRIB
  • Analyst Count
  • AMOD 0
  • TRIB 0
  • Target Price
  • AMOD N/A
  • TRIB N/A
  • AVG Volume (30 Days)
  • AMOD 13.4M
  • TRIB 6.3M
  • Earning Date
  • AMOD 01-01-0001
  • TRIB 04-03-2025
  • Dividend Yield
  • AMOD N/A
  • TRIB N/A
  • EPS Growth
  • AMOD N/A
  • TRIB N/A
  • EPS
  • AMOD N/A
  • TRIB N/A
  • Revenue
  • AMOD N/A
  • TRIB $59,126,000.00
  • Revenue This Year
  • AMOD N/A
  • TRIB $11.63
  • Revenue Next Year
  • AMOD N/A
  • TRIB $10.13
  • P/E Ratio
  • AMOD N/A
  • TRIB N/A
  • Revenue Growth
  • AMOD N/A
  • TRIB N/A
  • 52 Week Low
  • AMOD $1.32
  • TRIB $0.73
  • 52 Week High
  • AMOD $13.49
  • TRIB $3.55
  • Technical
  • Relative Strength Index (RSI)
  • AMOD N/A
  • TRIB 43.29
  • Support Level
  • AMOD N/A
  • TRIB $0.73
  • Resistance Level
  • AMOD N/A
  • TRIB $0.82
  • Average True Range (ATR)
  • AMOD 0.00
  • TRIB 0.06
  • MACD
  • AMOD 0.00
  • TRIB -0.01
  • Stochastic Oscillator
  • AMOD 0.00
  • TRIB 14.77

About AMOD ALPHA MODUS HOLDINGS INC

Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: